We recently described a number of inhibitors of P45017α, the key enzyme of androgen biosynthesis. Here, we report the synthesis and activity of novel 17-imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives as potential agents for the treatment of prostatic cancer. A number of 17-(4'-Imidazolyl) derivatives were prepared by condensing the corresponding 17- ketol acetate side chain with aldehyde and ammonium hydroxide. The 17β-(4'-imidazolyl) ...